Reporting guidelines for artificial intelligence in healthcare research

被引:35
作者
Ibrahim, Hussein [1 ,2 ,3 ]
Liu, Xiaoxuan [1 ,2 ,3 ,4 ,5 ,6 ]
Denniston, Alastair K. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ]
机构
[1] Univ Birmingham, Acad Unit Ophthalmol, Coll Med & Dent Sci, Inst Inflammat & Ageing, Birmingham B15 2TT, W Midlands, England
[2] Univ Hosp Birmingham NHS Fdn Trust, Dept Ophthalmol, Birmingham, W Midlands, England
[3] Birmingham Hlth Partners, Ctr Regulatory Sci & Innovat, Birmingham, W Midlands, England
[4] Moorfields Eye Hosp NHS Fdn Trust, NIHR Biomed Res Ctr, London, England
[5] UCL, London, England
[6] Hlth Data Res UK, London, England
[7] Univ Birmingham, Ctr Patient Reported Outcomes Res, Inst Appl Hlth Res, Birmingham, W Midlands, England
[8] UCL, Natl Inst Hlth Res, Biomed Res Ctr, Moorfields Eye Hosp NHS Fdn Trust,Inst Ophthalmol, London, England
关键词
artificial intelligence; checklist; guidelines; machine learning; research design; research report; DIABETIC-RETINOPATHY; RANDOMIZED-TRIALS; DEEP; PREDICTION; INTERVENTIONS; PROTOCOLS; DIAGNOSIS; OUTCOMES; CANCER; MODEL;
D O I
10.1111/ceo.13943
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Reporting guidelines are structured tools developed using explicit methodology that specify the minimum information required by researchers when reporting a study. The use of artificial intelligence (AI) reporting guidelines that address potential sources of bias specific to studies involving AI interventions has the potential to improve the quality of AI studies, through improvements in their design and delivery, and the completeness and transparency of their reporting. With a number of guidance documents relating to AI studies emerging from different specialist societies, this Review article provides researchers with some key principles for selecting the most appropriate reporting guidelines for a study involving an AI intervention. As the main determinants of a high-quality study are contained within the methodology of the study design rather than the intervention, researchers are recommended to use reporting guidelines that are specific to the study design, and then supplement them with AI-specific guidance contained within available AI reporting guidelines.
引用
收藏
页码:470 / 476
页数:7
相关论文
共 40 条
  • [1] Improved Automated Detection of Diabetic Retinopathy on a Publicly Available Dataset Through Integration of Deep Learning
    Abramoff, Michael David
    Lou, Yiyue
    Erginay, Ali
    Clarida, Warren
    Amelon, Ryan
    Folk, James C.
    Niemeijer, Meindert
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (13) : 5200 - 5206
  • [2] [Anonymous], LIB HLTH RES REP
  • [3] Artificial intelligence using deep learning to screen for referable and vision-threatening diabetic retinopathy in Africa: a clinical validation study
    Bellemo, Valentina
    Lim, Zhan W.
    Lim, Gilbert
    Nguyen, Quang D.
    Xie, Yuchen
    Yip, Michelle Y. T.
    Hamzah, Haslina
    Ho, Jinyi
    Lee, Xin Q.
    Hsu, Wynne
    Lee, Mong L.
    Musonda, Lillian
    Chandran, Manju
    Chipalo-Mutati, Grace
    Muma, Mulenga
    Tan, Gavin S. W.
    Sivaprasad, Sobha
    Menon, Geeta
    Wong, Tien Y.
    Ting, Daniel S. W.
    [J]. LANCET DIGITAL HEALTH, 2019, 1 (01): : E35 - E44
  • [4] Benaich N., 2020, State of AI report
  • [5] Bossuyt PM, 2015, BMJ-BRIT MED J, V351, DOI [10.1373/clinchem.2015.246280, 10.1136/bmj.h5527, 10.1148/radiol.2015151516]
  • [6] Guidelines for Inclusion of Patient-Reported Outcomes in Clinical Trial Protocols The SPIRIT-PRO Extension
    Calvert, Melanie
    Kyte, Derek
    Mercieca-Bebber, Rebecca
    Slade, Anita
    Chan, An-Wen
    King, Madeleine T.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 319 (05): : 483 - 494
  • [7] Reporting of Patient-Reported Outcomes in Randomized Trials The CONSORT PRO Extension
    Calvert, Melanie
    Blazeby, Jane
    Altman, Douglas G.
    Revicki, Dennis A.
    Moher, David
    Brundage, Michael D.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 309 (08): : 814 - 822
  • [8] Consort 2010 statement: extension to cluster randomised trials
    Campbell, Marion K.
    Piaggio, Gilda
    Elbourne, Diana R.
    Altman, Douglas G.
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2012, 345
  • [9] Beyond the hype of big data and artificial intelligence: building foundations for knowledge and wisdom
    Car, Josip
    Sheikh, Aziz
    Wicks, Paul
    Williams, Marc S.
    [J]. BMC MEDICINE, 2019, 17 (1)
  • [10] SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
    Chan, An-Wen
    Tetzlaff, Jennifer M.
    Gotzsche, Peter C.
    Altman, Douglas G.
    Mann, Howard
    Berlin, Jesse A.
    Dickersin, Kay
    Hrobjartsson, Asbjorn
    Schulz, Kenneth F.
    Parulekar, Wendy R.
    Krleza-Jeric, Karmela
    Laupacis, Andreas
    Moher, David
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2013, 346